Long-term Benefits of CPAP or MAD Treatment on the Sleep of OSAS Patients
← catalyst calendarSponsored by ResMed (industry) · RMD — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
400estimated
Sites
9
Country
France
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-07-15 | actual | When the study began enrolling |
| Primary completion | 2022-10-15 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-10-15 | estimated | The whole study's end, after follow-up |
| First posted | 2022-06-28 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-05-21 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- OSA
Interventions
- Device: CPAP
- Device: MAD
Primary outcome
what the primary-completion date above is the date OFTo determine the evolution of deep slow-wave sleep at one year in OSA patients according to the treatment initiated by continuous positive pressure or mandibular advancement device (MAD).
measured 12 months
Permalink · RMD's whole pipeline · Catalyst calendar · Every registered study · What changed